Össur hf. provided earnings guidance for the year 2024. The company's organic sales growth guidance is 5%-8%, expected to be driven by continued strong volume growth and moderate price increases.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.2 DKK | -1.02% | -3.01% | +5.65% |
04-23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
04-23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.65% | 1.82B | |
-11.98% | 20.83B | |
+10.33% | 14.2B | |
+10.47% | 10.08B | |
-12.14% | 2.2B | |
+35.10% | 1.66B | |
+23.26% | 644M | |
0.00% | 418M | |
+37.26% | 159M | |
+13.03% | 87.29M |
- Stock Market
- Equities
- EMBLA Stock
- News Embla Medical hf.
- Össur hf. Provides Earnings Guidance for the Year 2024